Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06796985 · ClinicalTrials.gov registry record · Phase 1
Botox for Chronic Pelvic Pain
A Phase 1 study of Pelvic Floor Disorders, sponsored by University of Miami.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06796985: Recruiting Phase 1 study of Pelvic Floor Disorders, sponsored by University of Miami.
NCT06796985 is a Phase 1 study of Pelvic Floor Disorders that is actively recruiting participants, run by University of Miami. The registered enrollment target is 30 participants, below the 113-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06796985, a Phase 1 study of Pelvic Floor Disorders, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) of targeted botulinum neurotoxin injections in women with pelvic floor disorders.
Primary Outcome
The muscle hypertonicity Index measured by using HD-sEMG which is a ratio between the root mean square (RMS) of pelvic floor muscle EMG at rest and contraction.
Conditions Studied
Interventions
- DRUG Botulinum neurotoxin
- DEVICE High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-02-24 |
| Est. Completion | 2027-03-22 |
| Phase | Phase 1 |
What NCT06796985 shows while recruiting
NCT06796985 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 113-participant average among 11 other Pelvic Floor Disorders trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Pelvic Floor Disorders appearing as the primary indexed condition, and to 2 interventions - of which Botulinum neurotoxin is the first listed.
NCT06796985 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06796985 about?
NCT06796985 is a clinical study titled "Botox for Chronic Pelvic Pain". The purpose of this research study is to find out if precise, targeted injection of botulinum neurotoxin (commonly known as Botox) provides better relief of pelvic floor hypertonicity and pain than the standard method being used. The researchers want to better understand the effects (good and bad) o...
What is the current status of trial NCT06796985?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2025-02-24. Estimated completion is 2027-03-22.
What conditions does trial NCT06796985 study?
This clinical trial studies the following conditions: Pelvic Floor Disorders.
What interventions are being tested in trial NCT06796985?
The interventions under investigation include: Botulinum neurotoxin (DRUG), High Density Surface Electromyographic, precision botulinum neurotoxin injection guidance medical device (DEVICE).
Who is sponsoring clinical trial NCT06796985?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06796985 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pelvic Floor Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06796985's enrollment target sits among peer trials
30 11th of 11 higher than 1 of 11 other Pelvic Floor Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pelvic Floor Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
Perineal Massage Using A Pelvic Wand During Pregnancy
RECRUITING · Phase 4
-
Improving Women's Function After Pelvic Radiation
ACTIVE NOT RECRUITING · NA
-
Study of Surgically-Induced Weight Loss on Pelvic Floor Disorders
COMPLETED
-
Pudendal Nerve Block in Vaginal Surgery
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI